Loss of T cell responses following long-term cryopreservation
- PMID: 17707394
- PMCID: PMC2065759
- DOI: 10.1016/j.jim.2007.07.012
Loss of T cell responses following long-term cryopreservation
Abstract
Although cryopreservation of peripheral blood mononuclear cells (PBMC) is a commonly used technique, the degree to which it affects subsequent functional studies has not been well defined. Here we demonstrate that long-term cryopreservation has detrimental effects on T cell IFN-gamma responses in human immunodeficiency virus (HIV) infected individuals. Long-term cryopreservation caused marked decreases in CD4(+) T cell responses to whole proteins (HIV p55 and cytomegalovirus (CMV) lysate) and HIV peptides, and more limited decreases in CD8(+) T cell responses to whole proteins. These losses were more apparent in cells stored for greater than one year compared to less than six months. CD8(+) T cell responses to peptides and peptide pools were well preserved. Loss of both CD4(+) and CD8(+) T cell responses to CMV peptide pools were minimal in HIV-negative individuals. Addition of exogenous antigen presenting cells (APC) did not restore CD4(+) T cell responses to peptide stimulation and partially restored T cell IFN-gamma responses to p55 protein. Overnight resting of thawed cells did not restore T cell IFN-gamma responses to peptide or whole protein stimulation. A selective loss of phenotypically defined effector cells did not explain the decrement of responses, although cryopreservation did increase CD4(+) T cell apoptosis, possibly contributing to the loss of responses. These data suggest that the impact of cryopreservation should be carefully considered in future vaccine and pathogenesis studies. In HIV-infected individuals short-term cryopreservation may be acceptable for measuring CD4(+) and CD8(+) T cell responses. Long-term cryopreservation, however, may lead to the loss of CD4(+) T cell responses and mild skewing of T cell phenotypic marker expression.
Figures








References
-
- Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 2001;193:169. - PMC - PubMed
-
- Amos CL, Woetmann A, Nielsen M, Geisler C, Odum N, Brown BL, Dobson PR. The role of caspase 3 and BclxL in the action of interleukin 7 (IL-7): a survival factor in activated human T cells. Cytokin. 1998;10:662. - PubMed
-
- Baust JM, Van B, Baust JG. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitro Cell. Dev Biol., Anim. 2000;36:262. - PubMed
-
- Birkeland SA. Cryopreservation of human lymphocytes for sequential testing of immune competence. J. Immunol. Methods. 1980;35:57. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 MH062246/MH/NIMH NIH HHS/United States
- M01 RR000833/RR/NCRR NIH HHS/United States
- AI41531/AI/NIAID NIH HHS/United States
- R01 AI049538/AI/NIAID NIH HHS/United States
- P30 NH59037/NH/NIH HHS/United States
- K08 AI001698/AI/NIAID NIH HHS/United States
- U54RR023566/RR/NCRR NIH HHS/United States
- M01 RR00083/RR/NCRR NIH HHS/United States
- AI055273/AI/NIAID NIH HHS/United States
- P30 NH62246/NH/NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- P30 MH059037/MH/NIMH NIH HHS/United States
- DPI OD00329/OD/NIH HHS/United States
- P30 AI27763/AI/NIAID NIH HHS/United States
- AI052745/AI/NIAID NIH HHS/United States
- AI47062/AI/NIAID NIH HHS/United States
- R21 AI055273/AI/NIAID NIH HHS/United States
- R01 AI052745/AI/NIAID NIH HHS/United States
- AI49538/AI/NIAID NIH HHS/United States
- DP1 OD000329/OD/NIH HHS/United States
- U01 AI041531/AI/NIAID NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- 5P30AI027763/AI/NIAID NIH HHS/United States
- R01 AI047062/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials